Table 2.
STAR participant milestones level, across the eight core competency levels by participant category.
| LEARNER CLASSIFICATION | INQUIRING | UNDERSTANDING | PRACTICING | LEADING | ADVANCING | CHI SQUARED (p-VALUE) |
|---|---|---|---|---|---|---|
| DEVELOPMENT PRACTICE | ||||||
| Intern | 3 (7.9%) | 28 (73.7%) | 7 (18.4%) | 0 (0.0%) | 0 (0.0%) | <0.001* |
| US-F | 0 (0.0%) | 4 (23.5%) | 6 (35.3%) | 6 (35.3%) | 1 (5.9%) | |
| LMIC-F | 2 (10.5%) | 10 (52.6%) | 6 (31.6%) | 0 (0.0%) | 1 (5.3%) | |
| Total | 5 (6.8%) | 42 (56.8%) | 19 (25.7%) | 6 (8.1%) | 2 (2.7%) | |
| COMMUNICATION & INTERPERSONAL EFFECTIVENESS | ||||||
| Intern | 2 (5.3%) | 22 (57.9%) | 14 (36.8%) | 0 (0.0%) | 0 (0.0%) | <0.001* |
| US-F | 0 (0.0%) | 0 (0.0%) | 6 (35.3%) | 10 (58.8%) | 1 (5.9%) | |
| LMIC-F | 0 (0.0%) | 0 (0.0%) | 16 (84.2%) | 2 (10.5%) | 1 (5.3%) | |
| Total | 2 (2.7%) | 22 (29.7%) | 36 (48.7%) | 12 (16.2%) | 2 (2.7%) | |
| CROSS-CULTURAL PRACTICE | ||||||
| Intern | 6 (15.8%) | 24 (63.2%) | 8 (21.0%) | 0 (0.0%) | 0 (0.0%) | <0.001* |
| US-F | 0 (0.0%) | 1 (5.9%) | 4 (23.5%) | 10 (58.8%) | 2 (11.8%) | |
| LMIC-F | 0 (0.0%) | 4 (21.0%) | 12 (63.2%) | 3 (15.8%) | 0 (0.0%) | |
| Total | 6 (8.1%) | 29 (39.2%) | 24 (32.4%) | 13 (17.6%) | 2 (2.7%) | |
| CAPACITY STRENGTHENING | ||||||
| Intern | 9 (23.7%) | 23 (60.5%) | 6 (15.8%) | 0 (0.0%) | 0 (0.0%) | <0.001* |
| US-F | 0 (0.0%) | 1 (5.9%) | 11 (64.7%) | 4 (23.5%) | 1 (5.9%) | |
| LMIC-F | 0 (0.0%) | 0 (0.0%) | 7 (36.8%) | 12 (63.2%) | 0 (0.0%) | |
| Total | 9 (12.2%) | 24 (32.4%) | 24 (32.4%) | 16 (21.6%) | 1 (1.4%) | |
| GLOBAL BURDEN OF DISEASE | ||||||
| Intern | 5 (13.2%) | 27 (71.0%) | 6 (15.8%) | 0 (0.0%) | 0 (0.0%) | <0.001* |
| US-F | 0 (0.0%) | 1 (5.9%) | 6 (35.3%) | 8 (47.1%) | 2 (11.8%) | |
| LMIC-F | 0 (0.0%) | 2 (10.5%) | 11 (57.9%) | 5 (26.3%) | 1 (5.3%) | |
| Total | 5 (6.8%) | 30 (40.5%) | 23 (31.1%) | 13 (17.6%) | 3 (4.0%) | |
| ETHICS | ||||||
| Intern | 8 (21.1%) | 29 (76.3%) | 1 (2.6%) | 0 (0.0%) | 0 (0.0%) | <0.001* |
| US-F | 0 (0.0%) | 6 (35.3%) | 7 (41.2%) | 4 (23.5%) | 0 (0.0%) | |
| LMIC-F | 3 (15.8%) | 8 (42.1%) | 8 (42.1%) | 0 (0.0%) | 0 (0.0%) | |
| Total | 11 (14.9%) | 43 (58.1%) | 16 (21.6%) | 4 (5.4%) | 0 (0.0%) | |
| HEALTH EQUALITY & SOCIAL JUSTICE | ||||||
| Intern | 7 (18.4%) | 23 (60.5%) | 8 (21.1%) | 0 (0.0%) | 0 (0.0%) | 0.001** |
| US-F | 1 (5.9%) | 3 (17.7%) | 9 (52.9%) | 4 (23.5%) | 0 (0.0%) | |
| LMIC-F | 1 (5.3%) | 6 (31.6%) | 11 (57.9%) | 1 (5.3%) | 0 (0.0%) | |
| Total | 9 (12.2%) | 32 (43.2%) | 28 (37.8%) | 5 (6.8%) | 0 (0.0%) | |
| GENDER EQUITY | ||||||
| Intern | 3 (7.9%) | 28 (73.7%) | 7 (18.4%) | 0 (0.0%) | 0 (0.0%) | <0.001* |
| US-F | 0 (0.0%) | 4 (23.5%) | 6 (35.3%) | 6 (35.3%) | 1 (5.9%) | |
| LMIC-F | 2 (10.5%) | 10 (52.6%) | 6 (31.6%) | 0 (0.0%) | 1 (5.3%) | |
| Total | 5 (6.8%) | 42 (56.8%) | 19 (25.7%) | 6 (8.1%) | 2 (2.7%) | |
Cells in italic signify the highest value.
Cells in bold signify the lowest value.
* Designates significance at the p < 0.001 level.
** Designates significance at the p < 0.05 level.